塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/04/27 | 5,689 | 5,737 | 5,670 | 5,686 | -42 | -0.7% | 930,900 |
2017/04/26 | 5,786 | 5,792 | 5,677 | 5,728 | -57 | -1% | 1,379,400 |
2017/04/25 | 5,800 | 5,814 | 5,726 | 5,785 | +4 | +0.1% | 1,155,000 |
2017/04/24 | 5,678 | 5,794 | 5,671 | 5,781 | +194 | +3.5% | 1,297,800 |
2017/04/21 | 5,581 | 5,608 | 5,535 | 5,587 | +32 | +0.6% | 1,106,300 |
2017/04/20 | 5,580 | 5,602 | 5,534 | 5,555 | -35 | -0.6% | 1,139,900 |
2017/04/19 | 5,580 | 5,639 | 5,564 | 5,590 | -28 | -0.5% | 1,060,100 |
2017/04/18 | 5,583 | 5,636 | 5,544 | 5,618 | +23 | +0.4% | 829,600 |
2017/04/17 | 5,535 | 5,639 | 5,535 | 5,595 | +63 | +1.1% | 879,800 |
2017/04/14 | 5,808 | 5,808 | 5,509 | 5,532 | -176 | -3.1% | 1,846,400 |
2017/04/13 | 5,651 | 5,722 | 5,651 | 5,708 | -20 | -0.3% | 885,300 |
2017/04/12 | 5,749 | 5,779 | 5,671 | 5,728 | -48 | -0.8% | 998,100 |
2017/04/11 | 5,768 | 5,806 | 5,742 | 5,776 | +2 | ±0% | 866,400 |
2017/04/10 | 5,882 | 5,909 | 5,765 | 5,774 | -95 | -1.6% | 1,008,300 |
2017/04/07 | 5,848 | 5,903 | 5,812 | 5,869 | +21 | +0.4% | 1,487,100 |
2017/04/06 | 5,907 | 5,925 | 5,821 | 5,848 | -34 | -0.6% | 1,302,500 |
2017/04/05 | 5,902 | 5,945 | 5,840 | 5,882 | -9 | -0.2% | 1,388,200 |
2017/04/04 | 5,815 | 5,948 | 5,808 | 5,891 | +80 | +1.4% | 1,814,800 |
2017/04/03 | 5,795 | 5,845 | 5,763 | 5,811 | +63 | +1.1% | 978,200 |
2017/03/31 | 5,825 | 5,850 | 5,748 | 5,748 | -52 | -0.9% | 956,900 |
2017/03/30 | 5,857 | 5,908 | 5,789 | 5,800 | -74 | -1.3% | 781,200 |
2017/03/29 | 5,838 | 5,918 | 5,812 | 5,874 | +28 | +0.5% | 1,235,200 |
2017/03/28 | 5,832 | 5,884 | 5,793 | 5,846 | +56 | +1% | 1,460,100 |
2017/03/27 | 5,776 | 5,837 | 5,757 | 5,790 | +13 | +0.2% | 1,505,100 |
2017/03/24 | 5,647 | 5,780 | 5,634 | 5,777 | +143 | +2.5% | 1,333,800 |
2017/03/23 | 5,597 | 5,646 | 5,590 | 5,634 | +57 | +1% | 915,600 |
2017/03/22 | 5,550 | 5,609 | 5,540 | 5,577 | -58 | -1% | 980,400 |
2017/03/21 | 5,645 | 5,674 | 5,608 | 5,635 | -11 | -0.2% | 1,006,600 |
2017/03/17 | 5,705 | 5,708 | 5,630 | 5,646 | -83 | -1.4% | 1,325,400 |
2017/03/16 | 5,740 | 5,763 | 5,707 | 5,729 | -4 | -0.1% | 1,020,000 |
2017/03/15 | 5,687 | 5,747 | 5,682 | 5,733 | +68 | +1.2% | 894,200 |
2017/03/14 | 5,664 | 5,676 | 5,635 | 5,665 | -16 | -0.3% | 763,400 |
2017/03/13 | 5,667 | 5,735 | 5,650 | 5,681 | -3 | -0.1% | 699,500 |
2017/03/10 | 5,619 | 5,693 | 5,599 | 5,684 | +141 | +2.5% | 1,979,000 |
2017/03/09 | 5,606 | 5,608 | 5,530 | 5,543 | -20 | -0.4% | 963,900 |
2017/03/08 | 5,572 | 5,572 | 5,532 | 5,563 | -16 | -0.3% | 939,500 |
2017/03/07 | 5,577 | 5,599 | 5,553 | 5,579 | +2 | ±0% | 678,700 |
2017/03/06 | 5,593 | 5,603 | 5,540 | 5,577 | -22 | -0.4% | 684,400 |
2017/03/03 | 5,683 | 5,714 | 5,577 | 5,599 | -56 | -1% | 1,132,600 |
2017/03/02 | 5,650 | 5,682 | 5,634 | 5,655 | +66 | +1.2% | 966,300 |
2017/03/01 | 5,540 | 5,627 | 5,510 | 5,589 | +91 | +1.7% | 1,495,900 |
2017/02/28 | 5,529 | 5,559 | 5,488 | 5,498 | -9 | -0.2% | 1,172,900 |
2017/02/27 | 5,593 | 5,602 | 5,491 | 5,507 | -129 | -2.3% | 2,572,200 |
2017/02/24 | 5,614 | 5,650 | 5,575 | 5,636 | -28 | -0.5% | 1,584,600 |
2017/02/23 | 5,608 | 5,667 | 5,579 | 5,664 | +110 | +2% | 1,216,200 |
2017/02/22 | 5,506 | 5,554 | 5,472 | 5,554 | +7 | +0.1% | 939,800 |
2017/02/21 | 5,496 | 5,547 | 5,493 | 5,547 | +57 | +1% | 592,400 |
2017/02/20 | 5,418 | 5,509 | 5,415 | 5,490 | +20 | +0.4% | 911,000 |
2017/02/17 | 5,383 | 5,477 | 5,372 | 5,470 | +19 | +0.3% | 1,047,900 |
2017/02/16 | 5,506 | 5,519 | 5,426 | 5,451 | -43 | -0.8% | 950,100 |
1851~
1900
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム